 |
Twice-Weekly Briefing
Tuesday, November 10, 2026
Issue 261110-79
|
|
|
The MOC Brief
Health policy, priced and translated for self-funded plan sponsors
|
|
In This Edition
Five developments, and what each one costs you.
| 1. | Your 2027 health FSA cap is $3,500, with a $700 carryover if your plan allows one. | | 2. | A tobacco surcharge class action against an employer settled for $3 million. | | 3. | A Florida health system told its carrier it intends to leave the commercial network at year end. | | 4. | A proposed decree would void contract terms that block or penalize tiered networks and reference-based pricing. | | 5. | A modelled all-payer sickle cell gene therapy pool would cost about 11 cents per member per month. |
|
|
| 1 · BENEFIT LIMITS · November 5, 2026 |
| The IRS Set the 2027 Health FSA Limit at $3,500 and the Carryover at $700 |
| The IRS released Rev. Proc. 2026-35 on November 5, 2026, carrying the inflation adjusted benefit figures for taxable years beginning in 2027. The dollar limitation on voluntary employee salary reductions for contributions to a health flexible spending arrangement is $3,500, which the agency's news release describes as up $100 from the prior year. If a cafeteria plan permits the carryover of unused amounts, the maximum carryover amount is $700, which the release calls an increase of $20 from tax years beginning in 2026. The monthly limitation for transportation in a commuter highway vehicle and any transit pass is $350, and the monthly limitation for qualified parking is also $350, up $10 from 2026. The release is numbered IR-2026-133. |
|
MOC Perspective
If your 2027 enrollment materials went out before November 5, they carry last year's figures. The new cap and the carryover have to reach employees before elections close, and a carryover only pays out if your plan document already permits one. The parking and transit figures move on the same schedule and sit in a different vendor's file, which is where they usually get missed.
What to do now
| ▪ | Pull your 2027 enrollment materials this week and correct the health FSA salary reduction cap before elections close. | | ▪ | Confirm your cafeteria plan document permits the $700 carryover, and amend it before your 2027 plan year starts if it does not. | | ▪ | Send your commuter benefit vendor the $350 monthly parking and transit figures before January 1, 2027. |
|
|
| Source: Internal Revenue Service, Rev. Proc. 2026-35, released November 5, 2026 |
|
| 2 · SURCHARGE LITIGATION · November 2, 2026 |
| A Court Awarded Class Counsel $999,900 From a $3 Million Settlement Over an Employer's Tobacco Surcharge |
| Judge Thomas L. Parker granted an unopposed motion for fees, costs and a case contribution award in Bailey v. Sedgwick Claims Management Services, Inc., No. 2:24-cv-02749-TLP-tmp, in the Western District of Tennessee, on November 2, 2026. The order awards class counsel $999,900 in attorneys' fees and $19,733.02 in litigation costs, plus a $7,500 contribution award to the named plaintiff, out of what the settlement agreement calls a non-reversionary Gross Settlement Amount of $3,000,000. The class action was brought on behalf of over 5,000 employees who paid tobacco or nicotine surcharges. An earlier order in the same case recorded that in 2024 Sedgwick charged those tobacco users a surcharge in the amount of $50 per pay period or $1,300 per year, with a cap of $150 per family per pay period. Sedgwick offers the plan at issue to its own employees. The November order decides no question of liability, finds no ERISA or HIPAA violation, and says nothing either way about an admission. |
|
MOC Perspective
The defendant's own name is Sedgwick Claims Management Services, and here it was the employer defending its own plan design rather than a vendor defending a client's. That is the seat you sit in. The court let only part of the case through: it found the Quit for Life program was a satisfactory reasonable alternative standard, so that argument failed. What survived was narrower and easier to miss, because the plan materials said nothing about accommodating a personal physician's recommendation. That is one line in one document, and it is what the settlement put a price on.
What to do now
| ▪ | Check every 2027 participant notice, before elections close, for language saying you will accommodate a personal physician's recommendation. | | ▪ | Compare your own tobacco surcharge against the $1,300 a year charged in this case, times your enrolled tobacco users, before your next renewal. | | ▪ | Ask benefits counsel in writing, before January 1, 2027, to name which document in your plan carries your reasonable alternative standard. |
|
|
| Source: W.D. Tenn., Bailey v. Sedgwick Claims Management Services, Inc., No. 2:24-cv-02749-TLP-tmp, order of November 2, 2026, GPO copy of the court's order |
|
| 3 · NETWORK EXIT · November 3, 2026 |
| UnitedHealthcare Says Lee Health Gave Notice It Intends to Leave the Commercial Network |
| UnitedHealthcare's page on Lee Health, as updated November 3, 2026, says the Florida health system notified the carrier in late August that it intends to leave the commercial and Medicare Advantage network beginning January 1, 2027. The same page says members continue to have network access to Lee Health through December 31, 2026, and that UnitedHealthcare gave the health system a proposal on October 30. People can apply for continuity of care at any time through 30 days after a provider has left the network, and must be approved. The page names commercial, Medicare Advantage, Individual Family Plan, Medicare Supplement and Medicare Advantage Group Retiree coverage, and it carries no count of hospitals, members or employers and no rate figure from either side. Lee Health is not quoted anywhere on it. |
|
MOC Perspective
Commercial is where your employer coverage sits, and the carrier has not broken out how many of those members are in a self-funded plan rather than a fully insured one. If you cover employees who use Lee Health, your network for 2027 changes at the turn of the year unless the two sides reach terms first. Everything readable here is one party's account of the other party's decision, so treat the rate dispute as unproven and the dates as the only firm facts.
What to do now
| ▪ | Run a claims report on Lee Health utilization for the last 12 months and count your affected members. | | ▪ | Ask your TPA before December 31, 2026 what continuity of care approval requires and who files it. | | ▪ | Get a written answer on whether your stop-loss carrier prices out-of-network claims differently after January 1, 2027. |
|
|
| Source: UnitedHealthcare, network update regarding Lee Health, page as updated November 3, 2026 |
|
| 4 · ANTITRUST DECREE · November 5, 2026 |
| A Proposed Consent Decree Would Void OhioHealth Contract Terms That Block or Penalize Tiered Networks |
| The Justice Department filed an amended response to public comments on the proposed final judgment in United States and State of Ohio v. OhioHealth Corporation, No. 2:26-cv-00207-ALM-SCS, on November 2, 2026, and the Federal Register published it on November 5. The notice says the United States received four comments about the proposed remedy, and that the only changes from the initial response sit on pages 12 and 13 of the filing, apart from the comment added to Exhibit A. The proposed final judgment of June 16, 2026 would make OhioHealth contract provisions that prohibit, deter, prevent or penalize steering, steered plans or transparency void and unenforceable. It says steered plans include, but are not limited to, Narrow Network Benefit Plans, Tiered Network Benefit Plans, or any Benefit Plans with Reference-Based Pricing, and its benefit plan definition reaches a self-funded benefit plan. Absent a court-granted extension the judgment would expire ten years from the date of entry, and a monitor would serve five years from appointment unless the United States, in its sole discretion, decides a different period is appropriate. No judgment has been entered, and OhioHealth consented to entry without the judgment constituting any admission. |
|
MOC Perspective
Narrow networks, tiered networks and reference-based pricing are the three designs a sponsor buys to move volume toward cheaper care, and this filing names all three. It reaches one health system in one state, and only through a July 2026 stipulation in which OhioHealth agreed to abide by the terms while it waits for entry. It changes nothing in your own agreements. What it gives you is language, a federal antitrust filing calling anti-steering and anti-transparency terms void, which is worth having in hand the next time a system asks for them.
What to do now
| ▪ | Search your three largest facility agreements for anti-steering and anti-tiering clauses before your next renewal. | | ▪ | Ask your network vendor in writing whether any contract penalizes reference-based pricing, and set a 30 day deadline for the answer. | | ▪ | Read the four public comments in the November 5 Federal Register notice if you cover employees in Ohio. |
|
|
| Source: Federal Register, amended response of the United States to public comments on the proposed Final Judgment, published November 5, 2026, GPO copy |
|
| 5 · GENE THERAPY COST · October 22, 2026 |
| A Managed Care Pharmacy Group Modelled a Sickle Cell Gene Therapy Pool at About 11 Cents a Member a Month |
| The Academy of Managed Care Pharmacy published a white paper on October 22, 2026 modelling what a national all-payer risk pool for sickle cell disease gene therapies would cost. Its key findings say such a pool would cost approximately 11 cents per member per month across a 337 million member insured population, and that this would equal $13,200 a year for an employer that had 10,000 lives in their plan. The figure runs as low as $0.02 with an uptake rate of 1% and as high as $0.22 with 10% uptake, and a separate rebate sensitivity varies from $0.11 at 23.1% rebates to $0.04 PMPM with a 75% rebate rate. The inputs are available list prices of $2,200,000 and $3,100,000, for Casgevy and Lyfgenia, an assumed rebate of 25%, an assumed 90,000 people in the United States with sickle cell disease, and assumptions that 5% are eligible and 5% of those are treated each year. That combination produces only 225 people treated annually in the model. The paper models the pool rather than recommending it, and closes by saying the financial case for a national risk pool is stronger than commonly assumed. |
|
MOC Perspective
A fee that small is the point of the paper, and its own translation puts it at $13,200 a year for a plan of 10,000 lives, against list prices above two million dollars a therapy. The rate is spread across all public and private payers and an insured population of 337 million, so it is not an employer plan rate, and no such pool exists today. Your exposure is still one claim at a time, which means your stop-loss contract and any gene therapy carve-out are carrying it alone.
What to do now
| ▪ | Ask your stop-loss carrier in writing, within 30 days, what your specific deductible does with a single gene therapy claim at the $2,200,000 list price the paper uses. | | ▪ | Get a count from your TPA of plan members carrying a sickle cell disease diagnosis before your next renewal. | | ▪ | Price a gene therapy carve-out against your own headcount before your next stop-loss renewal. |
|
|
| Source: Academy of Managed Care Pharmacy, white paper on estimating the costs of gene therapies for sickle cell disease in a national all-payer risk pool, dated October 22, 2026 on AMCP's letters, statements and analysis index |
|
|
The Bottom Line
Every story here points at a document rather than a decision: your enrollment materials, your surcharge notices, a carrier's network page, a facility agreement, a stop-loss contract. Two of the five carry a date already on the calendar, because the health FSA figures have to reach employees before elections close and Lee Health's network status is set to change on January 1, 2027 unless the two sides reach terms first. The Ohio decree and the gene therapy paper carry no deadline at all, which is exactly why they will still be sitting there in March unless you put them on a calendar now. The cheapest week to read a contract is always the one before you have to sign it.
|
|
|
Jude Odu
Founder and Principal, Model Optimal Care
Author of Model Optimal Care: End U.S. Healthcare Waste, One Health Plan at a Time
|
|
|
|